Clinical Trial Update: A Prospective Study of Femtosecond Laser Intracorneal Lensectomi [Phase 3]

View source ↗

Summary

A Phase 3 prospective trial evaluating femtosecond laser intracorneal lentectomy for myopia and astigmatism has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Astigmatism
• Myopia

Drugs mentioned

• Femtosecond Laser Intracorneal Lensectomi

Snippet

Sponsor: Odense University Hospital | Conditions: Myopia, Astigmatism | Phase 3 | Status: COMPLETED